Viewing Study NCT03466320


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT03466320
Status: COMPLETED
Last Update Posted: 2021-05-04
First Post: 2018-02-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2
Sponsor: Celyad Oncology SA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module